中华实验和临床病毒学杂志
中華實驗和臨床病毒學雜誌
중화실험화림상병독학잡지
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL VIROLOGY
2008年
6期
440-442
,共3页
商庆华%于建国%徐传镇%安永%刘福义%孙思才%张光曙
商慶華%于建國%徐傳鎮%安永%劉福義%孫思纔%張光曙
상경화%우건국%서전진%안영%류복의%손사재%장광서
聚合酶链反应%肝炎,病毒性,人%肝炎病毒,乙型
聚閤酶鏈反應%肝炎,病毒性,人%肝炎病毒,乙型
취합매련반응%간염,병독성,인%간염병독,을형
Polymerase China Reaction%Hepatitis,Viral,human%Hepatitis B Virus
目的 观察非甲-非戊型慢性病毒性肝炎患者隐匿性HBV感染的状况,探讨荧光定量聚合酶链反应(FQ-PCR)技术对隐匿性HBV感染的诊断价值.方法 应用FQ-PCR技术对57例非甲-非戊型慢性病毒性肝炎患者进行了血清、肝组织HBV-DNA定量检测,并将肝组织HBV DNA定量水平与肝脏炎症活动度的关系进行了分析.结果 血清、肝组织HBV DrqA定量阳性分别为13例(22.81%)、22例(38.60%).13例血清HBV DNA定量阳性患者其肝组织定量亦均阳性,但9例肝组织HBV DrqA定量阳性患者其血清定量为阴性,差异有统计学意义(P<0.01);同时13例血清与肝组织定量均阳性患者比较.显示肝组织HBV DNA定量水平显著高于血清定量水平[(6.62±1.21)拷贝,gvs.(4.03±1.06)拷贝/ml,(P<0.01)].肝组织HBV DNA水平与肝脏炎症活动度并无相关性,10例G2,7例G3,5例G4患者HB'q DNA定量分别为(6.13±1.65)拷贝/g、(5.92±1.81)拷贝,g、(5.83±1.89)拷贝/g,(P0.05),但HBV DNA定量阳性患者均为活动性肝脏病变.结论 HBV隐匿性感染是部分非甲-非戊型慢性病毒性肝炎患者的病因.单纯检测血清免疫学标志物对HBV感染诊断存在漏诊,对非甲-非戊型慢性病毒性肝炎患者应用FQ-PCR技术开展血清定量尤其是肝组织中HBV DNA定量检测可提高HBV感染的诊断.对隐匿性HBV感染的慢性病毒性肝炎亦应给予有效的抗病毒治疗.
目的 觀察非甲-非戊型慢性病毒性肝炎患者隱匿性HBV感染的狀況,探討熒光定量聚閤酶鏈反應(FQ-PCR)技術對隱匿性HBV感染的診斷價值.方法 應用FQ-PCR技術對57例非甲-非戊型慢性病毒性肝炎患者進行瞭血清、肝組織HBV-DNA定量檢測,併將肝組織HBV DNA定量水平與肝髒炎癥活動度的關繫進行瞭分析.結果 血清、肝組織HBV DrqA定量暘性分彆為13例(22.81%)、22例(38.60%).13例血清HBV DNA定量暘性患者其肝組織定量亦均暘性,但9例肝組織HBV DrqA定量暘性患者其血清定量為陰性,差異有統計學意義(P<0.01);同時13例血清與肝組織定量均暘性患者比較.顯示肝組織HBV DNA定量水平顯著高于血清定量水平[(6.62±1.21)拷貝,gvs.(4.03±1.06)拷貝/ml,(P<0.01)].肝組織HBV DNA水平與肝髒炎癥活動度併無相關性,10例G2,7例G3,5例G4患者HB'q DNA定量分彆為(6.13±1.65)拷貝/g、(5.92±1.81)拷貝,g、(5.83±1.89)拷貝/g,(P0.05),但HBV DNA定量暘性患者均為活動性肝髒病變.結論 HBV隱匿性感染是部分非甲-非戊型慢性病毒性肝炎患者的病因.單純檢測血清免疫學標誌物對HBV感染診斷存在漏診,對非甲-非戊型慢性病毒性肝炎患者應用FQ-PCR技術開展血清定量尤其是肝組織中HBV DNA定量檢測可提高HBV感染的診斷.對隱匿性HBV感染的慢性病毒性肝炎亦應給予有效的抗病毒治療.
목적 관찰비갑-비무형만성병독성간염환자은닉성HBV감염적상황,탐토형광정량취합매련반응(FQ-PCR)기술대은닉성HBV감염적진단개치.방법 응용FQ-PCR기술대57례비갑-비무형만성병독성간염환자진행료혈청、간조직HBV-DNA정량검측,병장간조직HBV DNA정량수평여간장염증활동도적관계진행료분석.결과 혈청、간조직HBV DrqA정량양성분별위13례(22.81%)、22례(38.60%).13례혈청HBV DNA정량양성환자기간조직정량역균양성,단9례간조직HBV DrqA정량양성환자기혈청정량위음성,차이유통계학의의(P<0.01);동시13례혈청여간조직정량균양성환자비교.현시간조직HBV DNA정량수평현저고우혈청정량수평[(6.62±1.21)고패,gvs.(4.03±1.06)고패/ml,(P<0.01)].간조직HBV DNA수평여간장염증활동도병무상관성,10례G2,7례G3,5례G4환자HB'q DNA정량분별위(6.13±1.65)고패/g、(5.92±1.81)고패,g、(5.83±1.89)고패/g,(P0.05),단HBV DNA정량양성환자균위활동성간장병변.결론 HBV은닉성감염시부분비갑-비무형만성병독성간염환자적병인.단순검측혈청면역학표지물대HBV감염진단존재루진,대비갑-비무형만성병독성간염환자응용FQ-PCR기술개전혈청정량우기시간조직중HBV DNA정량검측가제고HBV감염적진단.대은닉성HBV감염적만성병독성간염역응급여유효적항병독치료.
Objective To observe the status of occuh hepatitis B virus infection in chronic viral hepatitis patients with non-A to E hepatitis virus infection and explore the diagnostic value of fluorescence quantitative polymerase chain reaction (FQ-PCR) technique for occult hepatitis B virus infection. Methods The amount of HBV-DNA in serum and liver tissue from 57 patients with non-A to E hepatitis virus infection who were diagnosed as chronic viral hepatitis by Menghini method liver biopsy were detected by using FQ-PCR technique,then the relation between the viral load of HBV DNA in liver tissue and hepatic inflammatory activity were analyzed.Results Thirteen (22.81% ),22 (38.60%) patients were positive for HBV DNA in serum and liver tissue,respectively.The positive rate and the level of HBV DNA quantity in liver tissue were significantly higher than those in serum;HBV DNA was found positive in both serum and liver tissue in 13 cases,negative in both serum and liver tissue in 35,positive in liver tissue but negative in serum in 9,and in none of the cases HBV DNA was positive in serum but negative in liver tissue ( P<0.01 ).The logarithmic value of HBV DNA from 13 patients in liver tissue and in serum was respectively:(6.62±1.21 ) copies/g vs.(4.03±1.06) copies/ml,P < 0.01.The hepatic lesions of all HBV DNA positive patients were active pathologic changes,but the level of HBV DNA in liver tissue was not significantly correlated with the grade of hepatic inflammation activity ( P0.05 ).Conclusion Occult HBV infection is the etiology of part of the chronic viral hepatitis patients with non-A-E hepatitis virus infection.Missed diagnosis will occur if diagnosis of hepatitis B is only hased on detection of serum HBV markers. It is useful for improvement of the diagnostic level of HBV infection via detection of HBV DNA quantitatively in serum especially in liver tissue of chronic viral hepatitis with non-A-E hepatitis virus infection by using FQ-PCR technique The chronic viral hepatitis patients occult HBV infection should be also given effective anti-viral therapy.